Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
Medicenna Therapeutics Corp. (T.MDN) had Return on Tangible Equity of -61.99% for the most recently reported fiscal year, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
-8.48M |
|
-- |
|
-- |
|
-- |
|
-14.66M |
|
-- |
|
-8.48M |
|
-8.48M |
|
-8.48M |
|
-8.48M |
|
-8.48M |
|
-8.48M |
|
-14.66M |
|
-14.62M |
|
76.67M |
|
76.67M |
|
-0.11 |
|
-0.11 |
|
| Balance Sheet Financials | |
-- |
|
-- |
|
-- |
|
20.39M |
|
-- |
|
-- |
|
-- |
|
6.67M |
|
13.72M |
|
13.68M |
|
13.72M |
|
78.22M |
|
| Cash Flow Statement Financials | |
-11.85M |
|
-0.02M |
|
16.88M |
|
12.20M |
|
17.84M |
|
5.64M |
|
1.59M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.35 |
|
-- |
|
-- |
|
0.01 |
|
0.01 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-11.87M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-61.82% |
|
|
Return on Tangible Equity |
-61.99% |
-41.59% |
|
-61.44% |
|
0.24 |
|
-0.15 |
|
-0.15 |
|